Načítá se...
Protein Kinase A Inhibitor H89 Attenuates Experimental Proliferative Vitreoretinopathy
PURPOSE: This study aimed to explore the role of the protein kinase A (PKA) pathway in proliferative vitreoretinopathy (PVR) and the effect of the PKA inhibitor H89 on experimental PVR. METHODS: Epiretinal membranes (ERMs) were acquired from PVR patients and analyzed by frozen-section immunofluoresc...
Uloženo v:
| Vydáno v: | Invest Ophthalmol Vis Sci |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Association for Research in Vision and Ophthalmology
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7325625/ https://ncbi.nlm.nih.gov/pubmed/32031573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.61.2.1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|